文献速递肺结节与肺癌呼吸危重症与机械通气

Fissios应用与术后并发症(FPoC试验):多中心随机对照临床试验

Fissios and postoperative complications (FPoC trial): a multicentre, randomised, controlled clinical trial
RSS 订阅 · BMJ Open Respiratory Research

FPoC试验是一项多中心、前瞻性、随机、平行两组、对照、开放标签、优效性研究,旨在分析非小细胞肺癌(NSCLC)肺切除手术患者对标准化呼吸物理治疗方案的依从性与术后并发症的关系。研究计划纳入560例患者,随机分为仅面对面呼吸物理治疗组或Fissios应用作为呼吸物理治疗补充组,主要临床终点为住院期间术后并发症,预计研究时长12个月。

要点

  • FPoC试验比较Fissios应用辅助呼吸物理治疗与仅面对面呼吸物理治疗对NSCLC肺切除患者术后并发症的影响。
  • 计划纳入560例患者,1:1随机分组,主要终点为住院期间术后并发症。
  • Fissios应用包含标准化呼吸物理治疗方案,干预组可自由使用无时间地点限制。

核心结论

  • 该研究将建立NSCLC肺切除患者对标准化呼吸物理治疗方案的依从性与术后并发症发生之间的关系。

研究设计与样本

  • 多中心、前瞻性、随机、平行两组、对照、开放标签、优效性研究,计划纳入560例NSCLC肺切除手术患者,术前按1:1电子随机分组,每组每中心区组大小为6。
  • 干预组在面对面呼吸物理治疗基础上自由使用Fissios应用,对照组仅接受面对面呼吸物理治疗,主要临床终点为住院期间术后并发症,预计研究时长12个月。

关键数值与推荐

  • 主要临床终点为住院期间术后并发症。
  • 样本量基于术后呼吸并发症百分比及预期降低幅度计算,共需560例患者。
  • 随机化在术前进行,比例为1:1,每中心区组大小为6。

临床怎么用

  • NSCLC肺切除患者围手术期可在面对面呼吸物理治疗基础上使用Fissios应用作为补充,其标准化方案可能有助于降低术后并发症风险,但需待试验结果确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Introduction Respiratory physiotherapy as a part of a perioperative physical training programme may reduce the risk of developing postoperative complications in patients diagnosed with non-small cell lung carcinoma (NSCLC) scheduled for surgery. However, there is heterogeneity in the design, implementation and evaluation of respiratory physiotherapy programmes. Fissios App contains a standardised respiratory physiotherapy programme. Analysing the usage data, the patient’s personal history, the surgical procedure and the postoperative course, we will establish the relationship between compliance with a standardised respiratory physiotherapy programme and the development of postoperative complications in a group of patients diagnosed with NSCLC who underwent lung resection surgery. Methods and analysis The Fissios and postoperative complications trial is a multicentre, prospective, randomised, parallel two-group, controlled, open-label, superiority study of the use of only face-to-face respiratory physiotherapy or the use of Fissios App as a complement to respiratory physiotherapy. Based on the percentage of postoperative respiratory complications and the anticipated reduction, a total of 560 patients will be required. Patients will be electronically randomised to the intervention or control group before the surgery with a proportion of 1:1 in blocks of six for each centre. All patients will attend face-to-face respiratory physiotherapy sessions at the place and times established in each centre. In addition, patients in the intervention group will use the Fissios App freely and without restrictions in terms of hour of the day, usage time or location. The primary clinical endpoint is postoperative complications during hospital admission and the estimated duration of the study is 12 months. Ethics and dissemination This protocol was reviewed and approved by the Clinical Research and Clinical Trials Unit of Hospital Clínico San Carlos (Madrid, Spain) and complies with the ethics principles for medical research on humans stipulated in the Declaration of Helsinki of the World Medical Association. Trial registration number NCT06732193 .

来源:BMJ Open Respiratory Research,查看原文。版权归原作者所有。

引用

  1. BMJ Open Respiratory Research:Fissios and postoperative complications (FPoC trial): a multicentre, randomised, controlled clinical trial

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。